Fortea, J., & Ferrer-Picón, E. (2025). An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease.
Citación estilo ChicagoFortea, Juan|||0000-0002-1340-638X, y Elena Ferrer-Picón. An Overview of the Rivastigmine 13.3 Mg/24h Transdermal Patch As a Treatment Option for Alzheimer's Disease. 2025.
Cita MLAFortea, Juan|||0000-0002-1340-638X, y Elena Ferrer-Picón. An Overview of the Rivastigmine 13.3 Mg/24h Transdermal Patch As a Treatment Option for Alzheimer's Disease. 2025.
Precaución: Estas citas no son 100% exactas.